Ana Espinel‐Ingroff

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

John R. Perfect, Kieren A. Marr, Thomas J. Walsh et al. · Clinical Infectious Diseases · 2003 · 674 citations · Full text

Anti-infective Agents, Antifungal Agent, Health Sciences +13

Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

Ana Espinel‐Ingroff · Journal of Clinical Microbiology · 1998 · 576 citations · Full text

In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi

Ana Espinel‐Ingroff · Journal of Clinical Microbiology · 2001 · 291 citations · Full text

Comparison of the E-test with the NCCLS M38-P Method for Antifungal Susceptibility Testing of Common and Emerging Pathogenic Filamentous Fungi

Ana Espinel‐Ingroff · Journal of Clinical Microbiology · 2001 · 257 citations · Full text

Correlation of MIC with Outcome for <i>Candida</i> Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Michael A. Pfaller, Daniel J. Diekema, John Rex et al. · Journal of Clinical Microbiology · 2006 · 254 citations · Full text